Victor Ferreira, PhD
banner
victorhferreira.bsky.social
Victor Ferreira, PhD
@victorhferreira.bsky.social
70 followers 110 following 9 posts
Assistant Scientist, UHN Assistant Professor, University of Toronto Research interests: vaccine & viral immunology, elimination of latent viruses.
Posts Media Videos Starter Packs
I couldn’t have asked for a better partner than Dr. Victoria Hall who co-led this work with me. Thanks to the Ajmera Transplant Centre and PSI Foundation for their funding support, to Dr. Lavoie & his team, our UHN colleagues, and to the participants whose generosity made this work possible.
Reposted by Victor Ferreira, PhD
UHN, Canada’s top hospital, is ranked third in the world for the second year in a row by @newsweek.com! This 2025 ranking solidifies UHN’s Toronto General Hospital as the top publicly-funded hospital in the world.

Read the full report here:
www.newsweek.com/rankings/wor...
Reposted by Victor Ferreira, PhD
In Press and Open Access! "Using machine learning for personalized prediction of longitudinal coronavirus disease 2019 vaccine responses in transplant recipients" by Azarfar et al. https://buff.ly/43u19aH
@victorhferreira.bsky.social #MachineLearning #SolidOrganTransplantation #Vaccination
Can anyone shed light on the new CIHR rankings? Is it safe to assume that all projects that rank in top 10% will be funded? Do we expect that some applications in the 11-25% rank will also be funded?
Reposted by Victor Ferreira, PhD
JAMA @jama.com · Dec 30
While immunocompromised individuals had a heterogeneous antibody response to RSV vaccines, those who received the adjuvanted RSVPreF3-AS01 vaccine showed better neutralization.

ja.ma/4iVzJzy
Thanks to Dr. Ghazal Azarfar for her hard work on this study, and Dr. Mamatha Bhat, the UHN Transplant AI Initiative and fellow co-authors for their support.
Traditional and deep learning architectures were compared. "Routed LSTM", which combines capsule networks with LSTM to reduce the need for larger datasets, performed best (0.02 MSE and 0.79 PCC).

Key predictors included age, BMI, immunosuppression, breakthrough infection and transplant type.
Can machine learning be used to predict SARS-CoV-2 vaccine responses in immunocompromised transplant recipients one year after their first dose of vaccine?

Our latest study, accepted at American Journal of Transplantation, explores this question: tinyurl.com/59ehzfmk.
Using Machine Learning for Personalized Prediction of Longitudinal COVID-19 Vaccine Responses in Transplant Recipients
The COVID-19 pandemic has underscored the importance of vaccines, especially for immunocompromised populations like solid organ transplant (SOT) recip…
tinyurl.com
Pleased to share that our project (led by Victoria Hall, Atul Humar, Deepali Kumar, and myself) was one of 35 selected for funding to address the risk of avian influenza in Canada. We will study H5 vaccine responses & safety in immunocompromised transplant recipients.

www.canada.ca/en/institute...
Government of Canada invests in research on avian influenza A(H5N1) - Canada.ca
Avian influenza A(H5N1), commonly known as bird flu, is a viral disease that is typically transmitted between wild birds and poultry but can spread to other birds and mammals. Based on current evidenc...
www.canada.ca